Litigation Details for Galderma Laboratories, L.P. v. Alembic Pharmaceuticals Limited (D. Del. 2022)
✉ Email this page to a colleague
Galderma Laboratories, L.P. v. Alembic Pharmaceuticals Limited (D. Del. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-10-05 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Stephanos Bibas |
Jury Demand | None | Referred To | |
Patents | 7,749,532; 8,206,740 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Galderma Laboratories, L.P. v. Alembic Pharmaceuticals Limited
Details for Galderma Laboratories, L.P. v. Alembic Pharmaceuticals Limited (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-10-05 | 3 | ANDA Form | Expiration of Patent: 12/24/2025 (U.S. Patent No. 8,206,740) and 12/19/2027 (U.S. Patent No. 7,749,532).Thirty… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 5 October 2022 1:22-cv-01312 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-10-05 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2 ;8,206,740 B2. (… 5 October 2022 1:22-cv-01312 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |